Eduardo Azziz‐Baumgartner

Centers for Disease Control and Prevention — United States

Medicine · Health Sciences

46h-index17.1kcitations189works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(118), Respiratory viral infections research(96), Vaccine Coverage and Hesitancy(41), COVID-19 epidemiological studies(31), Pneumonia and Respiratory Infections(30)

Publications188 total

Improved Immune Response Against Influenza A Viruses With Receipt of a Recombinant Influenza Vaccine in Healthcare Personnel With Prior Low Antibody Response to Egg-Based Influenza Vaccines, Israel, 2019–2020
The Journal of Infectious Diseases·2025
Comparison of the immunogenicity of adjuvanted and conventional egg-based quadrivalent influenza vaccines among healthcare personnel in Lima, Peru: A randomized controlled trial
International Journal of Infectious Diseases·2025Open Access
Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative design
The Lancet Global Health·2025· 5 citedOpen Access
Evaluación de la incidencia de la enfermedad del virus respiratorio sincitial en un estudio de Cohorte de Nacimiento Prospectivo en Managua, Nicaragua
Translating the Americas·2025Open Access
Seasonal Influenza Vaccination Programs in the Americas: A Platform for Sustainable Life-Course Immunization and Its Role for Pandemic Preparedness and Response
Vaccines·2024· 6 citedOpen Access
A Potential Platform for Future Vaccine Trials Identifies a High Incidence of Symptomatic and Asymptomatic Influenza Infection Among Children Aged 6 to 23 Months in South Africa
The Journal of Infectious Diseases·2024Open Access
Laboratory-Confirmed Influenza Hospitalizations During Pregnancy or the Early Postpartum Period — Suzhou City, Jiangsu Province, China, 2018–2023
MMWR Morbidity and Mortality Weekly Report·2024· 5 citedOpen Access
The added value of serologic testing: A comparison of influenza incidence among pregnant persons based on molecular-based surveillance versus serologic testing
International Journal of Infectious Diseases·2024Open Access
Knowledge, attitudes, and practices associated with influenza vaccine uptake among healthcare personnel in Israel during three influenza seasons, 2016–2019
Vaccine·2024· 2 citedOpen Access
Estimating averted illnesses from influenza vaccination for children and pregnant women – El Salvador, Panama, and Peru, 2011–2018
Vaccine·2024· 6 citedOpen Access
Evaluation of cesarean delivery rates and factors associated with cesarean delivery among women enrolled in a pregnancy cohort study at two tertiary hospitals in Thailand
BMC Pregnancy and Childbirth·2024· 4 citedOpen Access
Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults
BMC Infectious Diseases·2024· 9 citedOpen Access
Influenza incidence, lineages, and vaccine effectiveness estimates in Lima, Peru, 2023
The Lancet Microbe·2024· 2 citedOpen Access
Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022
PLoS Medicine·2024· 27 citedOpen Access
Effectiveness of 2023 Southern Hemisphere Influenza Vaccines Against Hospitalization and Intensive Care Unit Admission – Pooled Estimates from Eight Countries Using the Test-Negative Design
SSRN Electronic Journal·2024Open Access
Laboratory-Confirmed Influenza Hospitalizations During Pregnancy or the Early Postpartum Period — Suzhou City, Jiangsu Province, China, 2018–2023
China CDC Weekly·2024Open Access
SARS-CoV-2 Infections, Vaccination, and Vaccine Effectiveness in Thailand, January 2021–January 2022: Results of a Cohort Study in Four Provinces
Outbreak Surveillance Investigation & Response (OSIR) Journal·2023· 2 citedOpen Access
Etiology of Acute Lower Respiratory Illness Hospitalizations Among Infants in 4 Countries
Open Forum Infectious Diseases·2023· 7 citedOpen Access
Effectiveness of COVID-19 vaccines against hospitalisation in Latin America during three pandemic waves, 2021–2022: a test-negative case-control design
The Lancet Regional Health - Americas·2023· 12 citedOpen Access
Cost of acute respiratory illness episode and its determinants among community-dwelling older adults: a four-site cohort study from India
BMJ Public Health·2023· 2 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Mark G. Thompson(13), Alicia M. Fry(13), Allison L. Naleway(11), Marc‐Alain Widdowson(10), Joseph Bresee(9), Mustafizur Rahman(9), Manjusha Gaglani(9), Stephen P. Luby(9), Monica Dickerson(8), Catherine H. Bozio(8), Ned Lewis(8), Stephanie A. Irving(8), Kristin Goddard(8), Stephanie J. Schrag(8), Nicola P. Klein(8), Emily S. Gurley(8), Cheryl Cohen(7), W. Abdullah Brooks(7), Edward Stenehjem(7), Shaun J. Grannis(7)